Geode Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98B | Sell |
|
|||||
|
2025
Q1 | $2.25B | Buy |
|
|||||
|
2024
Q4 | $1.83B | Buy |
|
|||||
|
2024
Q3 | $2.51B | Buy |
|
|||||
|
2024
Q2 | $2.57B | Buy |
|
|||||
|
2024
Q1 | $2.43B | Buy |
|
|||||
|
2023
Q4 | $2.12B | Buy |
|
|||||
|
2023
Q3 | $1.92B | Buy |
|
|||||
|
2023
Q2 | $1.92B | Buy |
|
|||||
|
2023
Q1 | $1.96B | Buy |
|
|||||
|
2022
Q4 | $2.16B | Buy |
|
|||||
|
2022
Q3 | $1.91B | Buy |
|
|||||
|
2022
Q2 | $1.99B | Buy |
|
|||||
|
2022
Q1 | $1.96B | Sell |
|
|||||
|
2021
Q4 | $1.93B | Buy |
|
|||||
|
2021
Q3 | $1.53B | Buy |
|
|||||
|
2021
Q2 | $1.51B | Buy |
|
|||||
|
2021
Q1 | $1.36B | Buy |
|
|||||
|
2020
Q4 | $1.19B | Sell |
|
|||||
|
2020
Q3 | $1B | Sell |
|
|||||
|
2020
Q2 | $992M | Buy |
|
|||||
|
2020
Q1 | $843M | Sell |
|
|||||
|
2019
Q4 | $1.12B | Buy |
|
|||||
|
2019
Q3 | $849M | Sell |
|
|||||
|
2019
Q2 | $1.02B | Sell |
|
|||||
|
2019
Q1 | $1.04B | Buy |
|
|||||
|
2018
Q4 | $888M | Buy |
|
|||||
|
2018
Q3 | $852M | Buy |
|
|||||
|
2018
Q2 | $719M | Buy |
|
|||||
|
2018
Q1 | $642M | Buy |
|
|||||
|
2017
Q4 | $643M | Buy |
|
|||||
|
2017
Q3 | $533M | Buy |
|
|||||
|
2017
Q2 | $513M | Buy |
|
|||||
|
2017
Q1 | $445M | Buy |
|
|||||
|
2016
Q4 | $357M | Buy |
|
|||||
|
2016
Q3 | $297M | Buy |
|
|||||
|
2016
Q2 | $298M | Buy |
|
|||||
|
2016
Q1 | $311K | Buy |
|
|||||
|
2015
Q4 | $306M | Buy |
|
|||||
|
2015
Q3 | $303M | Buy |
|
|||||
|
2015
Q2 | $354M | Sell |
|
|||||
|
2015
Q1 | $338M | Buy |
|
|||||
|
2014
Q4 | $267M | Buy |
|
|||||
|
2014
Q3 | $249M | Sell |
|
|||||
|
2014
Q2 | $229M | Sell |
|
|||||
|
2014
Q1 | $216M | Sell |
|
|||||
|
2013
Q4 | $205M | Buy |
|
|||||
|
2013
Q3 | $176M | Buy |
|
|||||
|
2013
Q2 | $168M | Buy |
|